PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sinclair & Co.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Formulation Key to Over-Encapsulation, Metrics AAPS Poster Shows - Improper over-encapsulation compromises prodrug dissolution during stressed stability storage - MetricsInc.com / Sinclair-Co.com
Formulation Key to Over-Encapsulation, Metrics AAPS Poster Shows

 

NewswireToday - /newswire/ - Greenville, NC, United States, 2011/10/26 - Improper over-encapsulation compromises prodrug dissolution during stressed stability storage - MetricsInc.com / Sinclair-Co.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Even during over-encapsulation – a process some in the pharmaceutical industry would consider relatively trivial – smart formulation is critical to drug efficacy.

So demonstrated Dr. Brad Gold, director of pharmaceutical development and new technology at Metrics Inc., during his poster presentation Oct. 26 at the American Association of Pharmaceutical Scientists annual conference.

In his presentation, Gold described how a client’s promising prodrug tablet – over-encapsulated in gelatin and being used in clinical trials – failed to dissolve properly after stressed stability storage. The client approached Metrics, seeking understanding of the problem as well as solutions.

Gold supervises a team of scientists at Metrics responsible for pre-formulation, formulation development, process development and scale-up/transfer of solid dose products.

Over-encapsulation is a key component in double blind clinical trials where a new drug is examined for effectiveness in humans. Because it’s important to prevent trial participants from knowing which drug a patient receives, pharmaceutical companies place active and placebo tablets inside inert shells. “Hiding” the tablets through over-encapsulation ensures that every tablet looks exactly alike.

In over-encapsulation, however, pharmaceutical companies create an entirely new dosage form. And often the compatibility of ingredients in test tablets and their cloaking shells isn’t established. For this reason, companies store tablets under stable conditions for the duration of the study.

It’s well known that storing gelatin capsules in hot and humid conditions may impair dissolution performance of the capsules, and there also are known incompatibilities between gelatin shells and/or active ingredients and excipients, Gold said. In this case, the over-encapsulated prodrug liberated free formaldehyde as a degradant, slowing dissolution performance. A sharp-eyed chemist at the pharmaceutical company spotted the dissolution failures and contacted Metrics for help.

After identifying the problem, Metrics proposed two alternative capsule shells as solutions.

“What our thoughtful science demonstrates is that even with something as trivial as over-encapsulation, you really have to pay close attention to the fundamentals of good formulation,” Gold said. “Once Metrics properly formulated the over-encapsulated tablets, we were able to produce all the clinical batches the client needed to serve as reference for their comparative studies. We didn’t just identify the problem – we delivered a solution.”

Metrics, Inc. (metricsinc.com) is one of the most respected contract pharmaceutical development and manufacturing companies in the United States today. Started as an analytical laboratory in 1994, Metrics has evolved into a full-service provider of quality pharmaceutical formulation development; first-time-in-man (FTIM) formulations; clinical material manufacturing (CTM) for Phase I, II and III trials; commercial manufacturing; and analytical method development and validation services.

Headquartered in Greenville, N.C., Metrics has particular expertise in FTIM and Phase I, II, and III CTM manufacturing. The company has conducted more than 120 FTIM projects for different chemical entities in the last five years alone – while developing more than 700 batches of CTM in the same period.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sinclair & Co.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Formulation Key to Over-Encapsulation, Metrics AAPS Poster Shows

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Karen Stinneford - Sinclair-Co.com 
919-833-9102 kstinneford[.]sinclair-co.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sinclair & Co. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sinclair & Co. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Sub-Sahara Africa - Increase in Western Lifestyles Leads to Dire Need for Chronic Prescription Drugs Finds Frost & Sullivan
BD Initiates New Industry Alliance to Combat Rising Opioid Crisis
BTG and Society of Interventional Oncology to Explore Role of Minimally Invasive Therapies in Immuno-oncology
Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi
BD Announces Early Access Program for BD Resolve™ Single-Cell Analysis Platform
Precision Medicine Unlocks the Future of Targeted Therapy in the Global Healthcare Industry Finds Frost & Sullivan
Sciformix Corporation Receives Prestigious 2017 Global Outsourcing Customer Service Leadership Award from Frost & Sullivan
Arven Pharmaceuticals Selects GE Healthcare’s FlexFactory to Improve Turkish and Regional Access to Biopharmaceuticals
Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma
Cost-Containment and Client-Centric Services Catalyse European Custom Procedure Trays and Packs Market Finds Frost & Sullivan
New BD Institute for Medication Management Excellence Aims to Improve Patient Safety and Outcomes through Collaboration
New Varicose Vein Treatment Offers Minimally Invasive Non Surgical Procedure to Canadians
Greenphire and Exostar Partner to Deliver Seamless, Secure Access to Clinical Research Site Payment Solution
PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)